Marrone Bio Innovations Inc (MBII) Stock Analyst Ratings
NASDAQ:MBII - Nasdaq - US57165B1061 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to MBII. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.4. This target is 75.73% above the current price.
MBII was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about MBII.
In the previous month the buy percentage consensus was at a similar level.
MBII was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-09-22 | Roth Capital | Initiate | Buy |
| 2021-08-19 | Aegis Capital | Maintains | Buy |
| 2021-02-11 | Aegis Capital | Maintains | Buy |